In a 7-year-old child with elevated free triiodothyronine (FT3), high-normal free thyroxine (FT4), and normal thyroid-stimulating hormone (TSH), what is the likely interpretation and recommended management?

Interpretation and Management

This 7-year-old child has elevated FT3 (6.57 pmol/L) with normal FT4 (18.2 pmol/L) and normal TSH (3.84 mIU/L), which is NOT consistent with typical hyperthyroidism and requires careful evaluation to distinguish between normal pediatric physiology, thyroid hormone resistance, or early Graves' disease before initiating any treatment.

Key Diagnostic Considerations

Normal Pediatric Physiology vs. Pathology

The elevated FT3 in this child may represent normal age-related variation rather than disease. Children at age 7 years have significantly higher FT3 levels than adolescents and adults, with 23.2% of 7-year-olds having FT3 above the adult reference range 1. Recent studies confirm that 26.1% of children with normal TSH have FT3 values outside adult reference ranges, with 22.2% above the upper limit 2. This makes adult reference intervals highly misleading in pediatric patients.

Critical Differential Diagnosis

Given the elevated FT3 with non-suppressed TSH, you must consider:

1. Normal pediatric physiology (most likely given normal TSH)
2. Thyroid hormone resistance (RTHβ) - characterized by elevated FT3 and FT4 with normal or elevated TSH 3, 4
3. Early T3-predominant Graves' disease - though this typically shows suppressed TSH 5
4. Laboratory interference - particularly if the child is taking biotin supplements 5

Diagnostic Algorithm

Step 1: Clinical Assessment

Evaluate for:

• Hyperthyroid symptoms: tachycardia (heart rate >100 bpm), tremor, weight loss, heat intolerance, behavioral changes
• Goiter: palpate for thyroid enlargement
• Ophthalmopathy: proptosis, lid lag
• Family history: thyroid disease or similar thyroid function patterns in relatives
• Medication history: biotin supplementation (can cause false results) 5
• Neurodevelopmental concerns: ADHD or learning disabilities (present in 23-30% of RTHβ patients) 3

Step 2: Laboratory Workup

If the child is clinically euthyroid (no symptoms):

• Repeat thyroid function tests in 4-12 weeks to confirm persistence 6
• Measure TSH receptor antibodies (TRAb) - essential for Graves' disease diagnosis 5
• Check for biotin use and discontinue 72 hours before retesting if present 5

If TRAb is negative and abnormalities persist:

• Screen family members for similar thyroid function patterns 3, 4
• Consider genetic testing for THRB mutations if family screening suggests RTHβ 3

Step 3: Imaging (If Indicated)

Thyroid ultrasound is NOT necessary for diagnosis but can assess for:

• Goiter size and homogeneity 5
• Nodularity (though toxic adenomas are rare in children) 5

Thyroid scintigraphy is NOT required for Graves' disease diagnosis 5 but may help differentiate other causes if the clinical picture remains unclear.

Management Recommendations

If Clinically Euthyroid with Normal TSH

DO NOT initiate antithyroid medication. The normal TSH strongly argues against true hyperthyroidism requiring treatment 5. The elevated FT3 likely represents:

• Normal pediatric variation 2, 1
• Possible thyroid hormone resistance (benign, requires no treatment) 3, 4

Appropriate management:

• Observation with repeat testing in 4-12 weeks 6
• Family screening if pattern persists 3
• Reassurance if RTHβ is confirmed (benign condition) 3, 4

If TSH Becomes Suppressed (<0.01 mIU/L) and TRAb Positive

This would indicate Graves' disease, requiring:

• Methimazole (carbimazole or thiamazole) at 0.4-0.8 mg/kg/day (max 30 mg/day) 5
• Propylthiouracil is CONTRAINDICATED in children due to hepatotoxicity risk 5, 7
• Beta-blockers (atenolol 1-2 mg/kg/day or propranolol 1-2 mg/kg/day in divided doses) if heart rate >100 bpm or significant symptoms 7

If Symptomatic Despite Normal TSH

• Beta-adrenergic blockade for tachycardia or tremor 7
• Urgent endocrinology referral for further evaluation
• Avoid antithyroid drugs until diagnosis is clarified

Critical Pitfalls to Avoid

1. Do not treat based on elevated FT3 alone - TSH is the most reliable screening parameter in children 6
2. Do not use adult reference ranges - this leads to misdiagnosis in >20% of children 2, 1
3. Do not assume hyperthyroidism with normal TSH - consider RTHβ and normal pediatric variation first 3, 4
4. Do not prescribe propylthiouracil - it is contraindicated in children 5, 7
5. Do not start treatment without confirming diagnosis - misdiagnosis can lead to unnecessary interventions 3

Monitoring Strategy

If observation is chosen:

• Repeat TSH, FT4, and FT3 in 4-12 weeks 6
• If TSH remains normal and child is asymptomatic, no treatment is needed
• If TSH becomes suppressed, measure TRAb and proceed with Graves' disease workup 5

Referral to pediatric endocrinology is warranted if:

• TSH becomes suppressed with elevated thyroid hormones
• Diagnostic uncertainty persists after initial workup
• Family screening suggests RTHβ requiring genetic confirmation 5, 3